Tianshui Zhongxing Bio-technology Co

Tianshui Zhongxing Bio-technology Co EBITDA per Share

The EBITDA per Share of Tianshui Zhongxing Bio-technology Co (002772.SZ) as of Nov 2, 2026 is 0.87 CNY. In the previous year, EBITDA per Share was 0.36 CNY — a change of 142.50% (higher).

EBITDA per Share

0.87CNY

YoY

142.50%

Last updated:

EBITDA per Share of Tianshui Zhongxing Bio-technology Co is 2025 0.87 CNY. EBITDA per Share of Tianshui Zhongxing Bio-technology Co was 2024 0.36 CNY. It decreases by 142.50% higher compared to the previous year.

The Tianshui Zhongxing Bio-technology Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.33 CNY
Jan 1, 2019
0.23 CNY
Jan 1, 2020
0.62 CNY
Jan 1, 2021
0.20 CNY
Jan 1, 2022
0.43 CNY
Jan 1, 2023
0.38 CNY
Jan 1, 2024
0.36 CNY
Jan 1, 2025
0.87 CNY
The Tianshui Zhongxing Bio-technology Co EBITDA per Share history
YEAREBITDA per ShareYoY
0.87CNY+142.50%
0.36CNY-6.08%
0.38CNY-10.14%
0.43CNY+114.29%
0.20CNY-68.22%
0.62CNY+176.56%
0.23CNY-31.21%
0.33CNY-15.17%
0.39CNY-13.75%
0.45CNY+50.26%
0.30CNY-20.47%
0.38CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tianshui Zhongxing Bio-technology Co Stock analysis

What does Tianshui Zhongxing Bio-technology Co do? Tianshui Zhongxing Bio-Technology Co., Ltd. generates revenue through the research, development, and manufacturing of edible and medical mushrooms. The company sells enoki mushroom, king oyster mushroom, and beech mushroom as its primary edible mushroom products. Through its subsidiaries, it also produces and sells medicinal mushroom, auxiliary materials, and agricultural by-products. The firm focuses on microbial technology, biological engineering, and new agricultural technologies for application and promotion. Its customer segments include consumers seeking edible and medicinal mushroom products, as well as businesses requiring agricultural technology solutions. The company's product portfolio includes edible mushrooms like enoki, king oyster, and beech varieties, alongside medicinal mushrooms and auxiliary materials. Subsidiaries handle production and distribution of these items, leveraging microbial and biological engineering technologies. The business targets both retail consumers and B2B clients in the agricultural and health sectors. Revenue streams are derived from direct sales of mushroom products and technology applications. Tianshui Zhongxing's operations are centered around edible and medical mushroom production, with subsidiaries expanding into agricultural by-products and technology services. The firm's revenue comes from selling enoki, king oyster, and beech mushrooms, medicinal mushrooms, and auxiliary materials. It serves markets requiring mushroom-based health products and agricultural technology innovations, with no mention of external partnerships or additional revenue sources. Tianshui Zhongxing Bio-technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tianshui Zhongxing Bio-technology Co stock

EBITDA per Share of Tianshui Zhongxing Bio-technology Co is 0.87 CNY in 2025.

EBITDA per Share of Tianshui Zhongxing Bio-technology Co changed from 0.36 CNY to 0.87 CNY, representing a 142.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Tianshui Zhongxing Bio-technology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Tianshui Zhongxing Bio-technology Co

All Key Metrics — Tianshui Zhongxing Bio-technology Co